News
1996; Hogrefe Verlag; Volume: 1; Issue: 4 Linguagem: Inglês
10.1027/1016-9040.1.4.326
ISSN1878-531X
Tópico(s)Psychology of Development and Education
ResumoFree AccessNews and AnnouncementsNewsPublished Online:November 10, 2006https://doi.org/10.1027/1016-9040.1.4.326PDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditE-Mail SectionsMoreThe Psychological Society of Ireland The Fifth European Congress of Psychology, 6-11 July 1997Beir Bua“Dancing on the Edge”The Psychological Society of Ireland is pleased to announce significant progress in the organization of the Fifth European Congress of Psychology, to be held in University College Dublin, Dublin, Ireland, 6-11 July 1997.The Final Program and Call for Contributions was launched at the XXVI International Congress of Psychology, Montreal, Canada, August 16-21, 1996, which was attended by some 4,500 psychologists. The Psychological Society of Ireland was warmly welcomed at Montreal as a member of IUPsyS. Members of the Organizing Committee were there to coordinate this significant launch. Personal promotional contact was established with over 2,500 psychologists from EFPPA, European Countries, North America, Australia/New Zealand, and the East. A highlight of our launch was the special reception organized by PSI and held at the Montreal Neurological Institute. Neuropsychologists Professor Brenda Milner and Dr. Gabriel Leonard most generously invited us to the Institute to hold the reception, which was attended by 200 representatives of European Federation of Professional Psychologists Associations (EFPPA), European Psychology Associations as well as European Scientific and Professional Societies. Representatives of the International Union of Psychological Science, the American Psychological Association, and the Canadian Psychological Association also supported the launch and made a warm commitment to the promotion of the Congress.The 10th Conference of the European Health Psychology Society, held in Dublin, 4-6 September 1996, and attended by 500 psychologists, provided a timely opportunity to promote the final announcement. The Congress is also being promoted at the British Psychological Society, Developmental Section Annual Conference, in St John's College Oxford in 11-13 September 1996.The Final Programme is available from the office of the Congress Secretariat (see address below). The Scientific Committee invited some 19 academic and professional psychologists of international repute to contribute keynote addresses and prepare their papers for a book entitled “ Dancing on the Edge: A Century of Psychology. ” The authors have responded creatively to the challenges presented by the Congress theme, and the book will be available at the Congress at a very reduced cost.Invited symposia on critical themes and issues are being coordinated by over 50 psychologists representing scientific and professional bodies across Europe, North America, and elsewhere.Some 26 member associates of EFPPA countries have expressed their strong support for the congress, and we expect to have a truly representative cohort of psychologists participating and coordinating symposia, workshops, interactive sessions, and papers from our European neighbours.We are now in the final but critical phase of our congress organization. A primary objective of this congress is to enable psychologists to present and showcase the rich range of research and practice developed in Europe and elsewhere.This Call for Contributions invites psychologists to coordinate and present symposia, workshops, interactive sessions as well as individual papers with their colleagues in Europe and abroad.As highlighted by Ingrid Lunt, President of EFPPA, this Congress follows EFPPA policy in seeking to bring together a large number of psychologists from different countries in Europe and elsewhere, and to make links between basic and applied research as well as between scientists and practitioners. These aspirations are the driving force of this congress.The deadline for contributions is 2 December 1996 . The Scientific Committee looks forward to this unique opportunity to facilitate psychologists from all core areas of the discipline to respond to this call. The congress, with a targeted attendance of 2000, will provide a tremendous opportunity for the strengthening of old and the development of new professional and research ties and networks among European and world psychologists.Psychologists in Ireland are working hard to make this congress a truly memorable and enjoyable event. Our objective is to ensure that all delegates will find a strong academic and professional program, lively and enjoyable social events and activities, comfortable accommodation, and — most of all — a warm Irish welcome.It is also our hope that coming to Dublin will provide a glimpse into the mystery of our “wisdom literature” and culture. We look forward to seeing you relaxing and enjoying the conversations, the humor, and the stories of our people. We trust that your stay in Dublin will be a momentous one, a time for reflection and a rich exchange of ideas and enjoyable discourse.We look forward to receiving your contributions and to meeting you in Dublin.Congress AddressesProfessor Eunice McCarthy, President, Dr Jim Livingstone, President, Fifth European Congress of Psychology 6-11 July 1997Congress Secretariat: Fifth European Congress of Psychology, 96 Haddington Road, Dublin 4, Ireland (tel. +353 1 6685442, fax +353 1 6685226, e-mail psi@iol.ie).Congress Organizers: A Touch of Ireland (Conferences) Ltd, 96 Haddington Road, Dublin 4, Ireland (tel. +353 1 6680888, fax +353 1 6680292, e-mail atoi@iol.ie).European Association of Psychological Assessment: 4th European Conference on Psychological Assessment, Lisbon, September 7-10, 19971st Announcement and Call for PapersThe 1997 Conference of the European Association of Psychological Assessment will be held at the University of Lisbon, Portugal, on September 7-10, 1997. The conference will cover a number of topics, such as diagnostic processes, assessment in personality, intelligence, behavior, neuropsychology, or psychophysiology, as well as the assessment in the different applied fields, such as clinical and health, education, forensic, work, or evaluation research. The official organ of the EAPA is the European Journal of Psychological Assessment .Persons wishing to organize a symposium, to present a paper, or a poster should send: a title;an abstract (200 words maximum) for the program book (paper and diskette version);name(s) and institutional affiliation(s) of the author(s); if there is more than one author, please indicate who will present the paper;some keywords;special materials required for presentation (e.g. slide projector, video);an address for contact (and a fax number or electronic mail address, if available).Submissions should be related to the above-mentioned areas. Diskettes should preferably be IBM-PC compatible. An overhead projector will be permanently available. Twenty minutes of program time is suggested for paper presentations, including discussion.The deadline for receipt of paper and symposium proposals is March 15, 1997 . Submissions of paper and symposium proposals as well as requests for information should be sent to Danilo Rodrigues Silva, 4th ECPA, Faculdade de Psicologia e de Ciências da Educação, Universidade de Lisboa, 1600 Lisboa, Portugal (tel. +351 1 7934554, fax +351 1 7933408, e-mail eapa.conf@fpce.ul.pt).2nd EAPA Award for Distinguished Scientific or Professional Contributions to Psychological AssessmentThe European Association of Psychological Assessment (EAPA) will present the EAPA Award for Distinguished Scientific or Professional Contributions to Psychological Assessment at the 4th European Conference on Psychological Assessment Lisbon, Portugal, September 7-10, 1997.The EAPA Award is endowed with 800 ECUs and will be presented to a young European psychologist who, in the opinion of the EAPA Award Committee, has made distinguished contributions to psychological assessment as a science or as a profession. The award winner will be invited to present an address on some phase or facet of his or her work at the 4th EAPA Conference in Lisbon.The award will be given to a psychologist under 40 years of age. Self-nomination as well as nomination by others are possible and should include, apart from a short statement of reasons, a curriculum vitae and the list of publications of the nominee. Nominations may be directed, until the end of May 1997, to the Award Chair: Prof. Dr. Eric E.E. De Bruyn, Antoinette van Pinxterenlaan 97, NL-6532 CV Nijmegen, The Netherlands (tel. +31 24 3612137, fax +31 24 3615938).Call for Papers for the 4th German Psychologists' Day in 1997The next congress of the “Berufsverband Deutscher Psychologinnen und Psychologen” (BDP) will take place at the University of Würzburg (Germany), 2-5 October 1997. The motto of this “4th German German Psychologists' Day” (simultaneously the 19th German Congress for Applied Psychology) is “Society in Midst of Change — Psychological Answers to Questions of our Time.” All colleagues are invited to submit papers for this conference. They can refer directly to the motto of the congress or to any field of psychology and its applications. For further informations and the detailed “Call for Papers” please contact: Bundesgeschäftsstelle des BDP, Re: Congress 1997, Heilsbachstr. 22, D-53123 Bonn, Germany.News from the European Union — European Commission DGXII/Science, Research, and Development: Biomedical and Health ResearchKurt Pawlik1. The First Call for Proposals: BIOMED 2The First Call for Proposals for the Biomedical and Health Research Program (1994-1998, BIOMED 2) closed on 31 March 1995. 1,709 proposals covering some 6,000 organizations and requesting a total of 1.7 billion ECU were received. Of these, 586 proposals were ranked as between high and outstanding in quality. Following the approval by the Commission of the short and reserve lists previously considered by the Program Committee, contract negotiations commenced. The available budget of 140 million ECU has now enabled the best 307 proposals to receive a research contract. More information on these research projects can be found in this newsletter.2. Second and Third Calls: A New Round for Applications in 1996These calls allow the scientific community to apply once again for RTD shared-cost projects or concerted actions within the framework of the Program. They are based on the revised Work Program Published in full on pages 10-22 of the previous Newsletter (Volume 7, Number 1, April 1996).The Second Call for Proposals covered areas 1, 2, 3, 4.2, 5 and 8.2 (demonstration projects in these areas); it closed on 17 June 1996. The Third Call will cover areas 4.1, 4.3-4.6, 6, 7, 8.1 and 8.2 (demonstration projects in these areas). It will open on Tuesday, 17 September 1996, and close on Tuesday, 17 December 1996, at 12 noon .3. The FellowshipsThe fellowship applications have their own separate time-table. The First Call had a deadline of 1 April 1996 and covered areas 1, 2, 3, and 5. Selection results will soon be available.Applications for research training grants in the other areas of the BIOMED program can now be submitted, the deadline being 31 December 1996.A final application round for fellowships covering all areas is foreseen to close on 31 December 1997.For all these initiatives the Information Package (1996 Edition) is now available on request from: European Commission — DG XII — E — 4 (Medical Research Unit), Square de Meeûs 8, B-1050 Brussels, Belgium, Fax +32 2 295 5365 .Contracts List for BIOMED 2 — First CallThe list of 307 projects selected for funding in 1995 and 1996 is given below. The breakdown by area across BIOMED 2 is as shown in the table below.The project leaders listed can be approached directly for more information concerning their project. New teams may be added without supplementary funding to existing networks (concerted actions) if the project leader and the steering or management group agree on scientific and organizational grounds. Further information can be obtained from the program management staff in Brussels:AREAS1.Pharmaceuticals Research:Dr G. Frachia2.Biomedical Technology and Engineering :Dr V. Thévenin3.Brain Research :Ad interim: Dr M. Vidal4.1Cancer Research :Dr S. Baig4.2AIDS, Tuberculosis and Other Infectious Diseases :Dr A. Lönroth4.3Cardiovascular Diseases :Dr M. Vidal4.4Chronic Diseases, Ageing and Age-related Diseases :Dr H. Kallasvaara4.5Occupational and Environmental Health :Dr K. Haavisto4.6Rare Diseases :Dr K. Haavisto5.Human Genome Research :Dr. M. Hallen6.Public Health Research, Including Health Services Research :Dr A. Vanvossel7.Biomedical Ethics :Dr C. Bardoux8.1Ethical, Legal and Social Aspects :Dr J. Elizalde8.2Demonstration Projects :Dr A. HerreroAll can be contacted by fax: +32 2 295 5365Excerpt listing of project reference information for BIOMED 2 - Areas related to psychology (1: project leader; 2: contact address)Area 3: Brain ResearchNeurotrophic factors in Parkinson's and Huntington's disease models: A gene therapy approach Dr. E. ARENASLaboratory of Molecular Neurobiology, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, BZ. lab., Doktorsringen 12 A plan 3, S-171 77 Stockholm, SwedenProperties of transporters for the neurotransmitters glutamate and glycine Prof. D. ATTWELLDept. of Physiology, University College London, Gower Street, London WC1E 6BT, UKMolecular and clinical neuropathology of Huntington's disease and spinocerebellar ataxia Dr. G. BATESUMDS, Division of Medical and Molecular Genetics, Guy's Hospital, London Bridge, London SE1 9RT, UKEuropean network on brain dysmyelinating disease (ENBDD): diagnostic, molecular and therapeutic approaches Dr. O. BOESPFLUG-TANGUYINSERM U384, Faculté de Médecine, Place H. Dunant 28, F-63001 Clermont-Ferrand Cedex, FranceIdentification, characterization and functional analysis of novel genes involved in early brain development Prof. E. BONCINELLIFondazione Centro San Raffaele del Monte Tabor — DIBIT, Via Olgettina 60, I-20132 Milan, ItalyMolecular properties and intraneuronal life-cycle of small and large densecored and synaptic vesicles Prof. A.B. DAHLSTRÖMInstitute of Anatomy and Cell Biology, Gothenburg University, Medicinaregtan 3-5, S-413 90 Gothenburg, SwedenThe outcome of depression in Europe: The effect of person-centred prevention in urban and rural settings Dr. C. DOWRICKDept. of Primary Care, University of Liverpool, Whelan Building, Liverpool L69 3BX, UKBrain imaging in developmental dyslexia Prof. U. FRITHMRC Cognitive Development Unit, 4 Taviton Street, London WC1H 0BT, UKDopaminergic receptors in the brain: Interactions with adenosine receptors Prof. K. FUXEDept. of Neuroscience, Division of Cellular and Molecular Neuro-chemistry, Karolinska Institutet, S-171 77 Stockholm, SwedenStudy of the relation of cardiovascular risk factors to dementia and cognitive impairment Prof. A. HOFMANDept. of Epidemiology & Biostatistics, Erasmus University Medical School, PO Box 1738, NL-3000 DR Rotterdam, The NetherlandsInflammatory neuropathy: cause and treatment Prof. R. HUGHESUMDS, Dept. of Neurology, Guy's Hospital, London SE1 9RT, UKMechanisms of intercellular signalling in Alzheimer's disease: the role of apolipoprotein E (MICAD) Dr. M. HÜTTINGERInstitute of Medical Chemistry, University of Vienna, Währingerstrasse 10, A-1090 Vienna, AustriaImpact of autism-related peptides and 5-HT system manipulations on cortical development and plasticity Prof. F. KELLERLaboratory of Neuroscience, Libero Istituto Universitario, Campus Bio-Medico, V. Longoni 83, I-00155 Rome, ItalyFundamental aspects of developmental plasticity of the cerebral cortex: implications for neurological disease Dr. H. KENNEDY“Cerveau et Vision,” INSERM U371, 18, avenue du Doyen Lépine, F-69675 Bron Cedex, FranceThe ?-opioid system and its role in pain control and drug addiction Dr. I. KITCHENSchool of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH, UKBasic mechanism of neurodegeneration in transmissible spongiform encephalopathies: Role of amyloidogenic prion protein PrP in glial activation Dr. J. P.M. LANGEVELDDLO-Institute for Animal Science and Health (ID-DLO), Edelhertweg 15, PO Box 65, NL-8200 AB Lelystad, The NetherlandsMechanisms of trigeminal pain Prof. M. LEANDRICIND, Via de Toni 5, I-16132 Genova, ItalyDevelopment of a cell transplantation therapy for patients with Parkinson's disease Prof. O. LINDVALLRestorative Neurology Unit, Dept. of Neurology, University Hospital, S-221 85 Lund, SwedenImmunoregulatory aspects of T cell autoimmunity in multiple sclerosis Dr. M. LONDEIDept. of Immunology, Sunley Division, Kennedy Institute of Rheumatology, 1 Lurgan Avenue, Hammersmith, London W6 8LW, UKRepair of damaged mammalian visual pathways Prof. R.D. LUNDInstitute of Ophthalmology, Bath Street, London EC1V 9EL, UKDevelopment of gene therapy strategies for neurological diseases Dr. J. MALLETLG.N., CNRS, Bâtiment CERVI, Hôpital de la Pitié-Salpêtrière, 83, boulevard de l'Hôpital, F-75013 Paris, FranceA multigenerational study of functional psychoses in a founder population Prof. P. McGUFFINDept. of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UKRole of intracellular receptors for calcium release in normal and abnormal brain function Prof. L. MISSIAENDept. of Physiology, K.U. Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, BelgiumObjective evaluation of cognitive brain function and dysfunction (CO-BRAIN) Prof. R. NAATANENCognitive Brain Research Unit, Dept. of Psychology, University of Helsinki, PO Box 11, SF-00014 Helsinki, FinlandHigh resolution structures of myelin proteins Prof. G. OURISSONCentre de Neurochimie, 5, rue Blaise Pascal, F-67084 Strasbourg, FranceTransgenic mouse models to study fragile X mental retardation Dr. B.A. OOSTRADept. of Clinical Genetics, Erasmus University, PO Box 1738, NL-3000 DR Rotterdam, The NetherlandsA multicentre randomized prospective trial comparing add-on therapy to alternative monotherapy in patients with partial seizures refractory to initial treatment Prof. E. PERUCCAClinical Pharmacology Unit, Dept. of Internal Medicine and Therapeutics, University of Pavia, Piazza Botta 10, I-27100 Pavia, ItalyRepair of injured spinal cord Dr. A. PRIVATINSERM U336 — USTL, Case Courrier 106, Place Eugène Bataillon, F-34095 Montpellier Cedex 05, FranceHomeoproteins and adhesion molecules in development and regeneration: targets for neurological diseases and tools for their treatments Dr. A. PROCHIANTZCNRS URA 1414, Ecole Normale Supérieure, rue d'Ulm 46, F-75230 Paris Cedex 05, FranceThe motor cortex: structural and functional analysis Prof. G. RIZZOLATTIIstituto di Fisiologia Umana, Università di Parma, Via Gramsci 14, I-43100 Parma, ItalyProliferation, differentiation, apoptosis: what's the difference? Dr. B. B. RUDKINCNRS — UMR 49, Laboratory of Molecular and Cellular Biology, Ecole Normale Supérieure de Lyon, allée d'Italie, 46, F-69364 Lyon Cedex 07, FranceNovel genes induced during ischaemic tolerance Prof. P. SEEBURGLaboratory of Molecular Neuroendocrinology, Centre for Molecular Biology (ZmBH), University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, GermanyThe dopamine D3 receptor in drug addiction and withdrawal: development of a novel therapeutic approach Dr. P. SOKOLOFFUnité de Neurobiologie et Pharmacologie, Centre Paul Broca de l'INSERM, 2ter, rue d'Alésia, F-75014 Paris, FranceMild therapeutic hypothermia to improve neurological outcome after cardiac arrest Dr. F. STERZAKH-Notfall (6/D), Währingergürtel 18-20, A-1090 Vienna, AustriaBasal ganglia mechanisms in motivation and learning Dr. E. TROUCHECNRS, chemin Joseph Aiguier 31, F-13402 Marseille Cedex 20, FranceSchizophrenia genes Prof. L. WETTERBERGDept. of Clinical Neuroscience, Karolinska Institute, St. Göran's Hospital, S-112 81 Stockholm, SwedenCellular and molecular mechanisms of ischaemic brain damage: Importance of nitric oxide Prof. T. WIELOCHLaboratory for Experimental Brain Research, Lund Hospital, S-221 85 Lund, SwedenChronic pain: toward new therapeutic approaches Dr. Z. WIESENFELD-HALLINDept. of Medical Laboratory Sciences and Technology, Section of Clinical Neurophysiology, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, SwedenGenetic susceptibility in Parkinson's disease Dr. N. WOODNeurogenetics Section, Dept. of Clinical Neurology, Institute of Neurology, Queen Square, London WC1N 3BG, UKSpatio-temporal emergence of the myelin-forming glial cells in the central nervous system: Molecular mechanisms and relevance to demyelinating diseases Dr. B. ZALCINSERM U134, Laboratoire de Neurobiologie Cellulaire, Moléculaire et Clinique, Hôpital de la Salpêtrière, F-75651 Paris Cedex 13, FranceNucleotides, a novel class of extracellular signalling substances in the nervous system Dr. H. ZIMMERMANNJ.W. Goethe Universität, Zoologisches Institut, AK Neurochemie, Marie Curie Strasse 9, D-60439 Frankfurt am Main, GermanyArea 4.4: Research on Chronic Diseases, Ageing and Age-related DiseasesNutritional primary prevention of Type 1 diabetes mellitus Dr. H.K. AKERBLOMThe Children's Hospital, University of Helsinki, Stenbäckinkatu 11, SF-00290 Helsinki, FinlandMediators of inflammation in asthma Prof. P.J. BARNESDept. of Thoracic Medicine, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UKBuilding of a European task force for the identification of non-insulin dependent diabetes mellitus (NIDDM) susceptibility genes in the insulin action cascade Prof. F. BEGUINOTDipt. di Biologia e Patologia Cellulare e Molecolare L., Califano, Facoltà di Medicina, Universitá di Napoli Federico II, Via S. Pansini, 5, I-80131 Naples, ItalyReactivation of foetal haemoglobin synthesis as a means to improve the quality of life of patients with haemoglobinopathies Prof. Y. BEUZARDLaboratoire Expérimental de Thérapie Génique, Institut Universitaire d'Hématologie, Université Denis Diderot Paris VII, Hôpital Saint-Louis, avenue Claude Velefaux 1, F-75475 Paris Cedex 10, FrancePan-European resource for assays for diabetes-related immune and genetic markers Dr. P.J. BINGLEYDept. of Diabetes and Metabolism, St. Bartholomew's Hospital, London EC1A 7BE, UKThe European newborn — An insulin dependent diabetes mellitus (IDDM) project Prof. G.F. BOTTAZZODept. of Immunology, London Hospital Medical College, Turner Street, London E1 2AD, UKCystic fibrosis: A model disease to set up procedures for cost-effective genetic testing and counselling in the European Union Prof. J.J. CASSIMANCenter for Human Genetics, University of Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, BelgiumImmunopathology of T cell-induced chronic inflammatory bowel disease Dr. M.H. CLAESSONDept. of Medical Anatomy, Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N, DenmarkGenetic factors predisposing to rheumatoid polyarthritis Dr. F. CORNELISCentro Viggo Petersen, Hôpital Lariboisière, rue Guy Patin 6, F-75010 Paris, FranceOptimization of target-effector interactions of prophylactic anti-rhesus D antibodies: Studies of structure-function relationships of variable and constant domains Dr. M. DZIEGIELBlodbanken K12031, Centre of Laboratory Medicine and Pathology, National University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, DenmarkNeutrophil-mediated lung injury: Genetic susceptibility and new interventional therapeutic strategies Prof. M.X. FITZGERALDDept. of Medicine and Therapeutics, University College Dublin, Woodview, Belfield, Dublin 4, IrelandEURODIAB — prospective complications study in diabetes mellitus Dr. J. FULLERDept. of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 6BT, UKEuropean nicotinamide diabetes intervention trial (ENDIT) Prof. E.A.M. GALEDept. of Diabetes and Metabolism, St Bartholomew's Hospital, 3rd Floor, Dominion House, 59 Bartholomew Close, London EC1A 7BE, UKAetiopathogenesis of reactive arthritis, Reiter's disease and ankylosing spondylitis: Abnormal host-microbe interaction Dr. K. GRANFORSNational Public Health Institute, Dept. in Turku, Kiinamyllynkatu 13, SF-20520 Turku, FinlandEURODIAB TIGER — Type I genetic epidemiology resource in diabetes mellitus Dr. A. GREENGenetic Epidemiology Research Unit, Odense University, Winslowparken 15-17, DK-5000 Odense C, DenmarkRole of apolipotrotein E in the pathogenesis of Alzheimer's disease and in atherosclerosis Dr. L.M. HAVEKESTNO-PG, Gaubius Laboratory, Zernikedreef 9, P.O.Box 2215, NL-2301 CE Leiden, The NetherlandsEuropean network for understanding the mechanisms of severe asthma (ENFUMOSA) Prof. S.T. HOLGATEUniversity Medicine, Level D, Centre Block, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UKInstallation of a European Centralized Facility for preclinical evaluation of immunotherapy in non-human primates Dr. M. JONKERBiomedical Primate Research Centre, Lange Kleiweg 151, P.O. Box 3306, NL-2288 GH Rijswijk, The NetherlandsSjögren's syndrome — A strategy for clarifying the disease process that underlies a chronic disorder of the mucous membranes Prof. R. JONSSONBroegelmann Research Laboratory for Microbiology, Armauer Hansen Building, University of Bergen, N-5021 Bergen, NorwayThe age-related motor handicap: Basic and clinical studies of skeletal muscle Dr. L. LARSSONDept. of Clinical Neurophysiology, Karolinska Hospital, S-104 01 Stockholm, SwedenOcular models for ageing and age-related diseases Prof. E. LÜTJEN-DRECOLLAnatomisches Institut II, Universität Erlangen/AWL-Mainz, Universitätsstrasse 19, D-91054 Erlangen, GermanyInduction of regulatory-protective cytokines in chronic arthritis Dr. P. MIOSSECDept. of Immunology and Rheumatology, Hôpital Edouard Herriot, Place d'Arsonval, F-69437 Lyon Cedex 03, FranceThe predictive value of HLA and other candidate genes for disease severity in British, Greek and Spanish rheumatoid arthritis patients Dr. W. OLLIERARC Epidemiology Research Unit, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UKMolecular and clinical research in photoreceptor disorders Prof. I.H. PAWLOWITSKIInstitut für Humangenetik, Westfälische Wilhelms-Universität, Vesaliusweg 12-14, D-48149 Münster, GermanyEuropean research network on congenital toxoplasmosis Dr. E. PETERSENLaboratory of Parasitology, Statens Seruminstitut, 5 Artillerivej, DK-2300 Copenhagen S, DenmarkFacility for the production of ? cell grafts in a network of basic and clinical research on transplantation in diabetes (? cell transplant) Prof. D. PIPELEERS? Cell Transplant, Central Unit, Medical Campus, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, BelgiumBiochemistry of leukotrienes, inflammatory and allergic mediators in the arachidonic acid cascade Prof. B. SAMUELSSONDept. of Medical Biochemistry and Biophysics, Division of Chemistry II, Karolinska Institutet, Solnavägen 1, S-171 77 Stockholm, SwedenLung disease in cystic fibrosis and accompanying changes in the glycosylation of salivary proteins Dr. D.K. SHORISecretory and Soft Tissue Research Unit, King's College School of Medicine and Dentistry, Rayne Institute, 123 Coldharbour Lane, London SE5 9NU, UKGrowth restriction intervention trial (GRIT) Dr. J.G. THORNTONInstitute of Epidemiology, University of Leeds, 34 Hyde Terrace, Leeds LS2 9LN, UKThe contribution of early environment to the development of insulin dependent diabetes mellitus (IDDM) in genetically susceptible children (EARLYBIRD) Prof. T.J. WILKINRoom 417, Davy Building, Post-graduate Medical School, University of Plymouth, Drake Circus, Plymouth PL4 8AA, UKArea 6: Public Health Research, including Health Services ResearchEuropean variation in stroke interventions from patients, carers, primary, ambulatory, community and hospital services: its impact on outcomes and costs Dr. R. BEECHUMDS, Dept. of Public Health Medicine, St. Thomas's Hospital, Lambeth Palace Road, London SE1 7EH, UKEurocommunication: a comparative study in five European countries on doctor-patient communication Prof. J.M. BENSINGNetherlands Institute of Primary Health Care (NIVEL), Drieharingstraat 6, P.O. Box 1568, NL-3500 BN Utrecht, The NetherlandsAttempted suicide in Europe Prof. U. BILLE-BRAHEUnit for Suicidological Research, Odense University Hospital, Tietgens Allé 108, DK-5230 Odense M, DenmarkAlcohol consumption and alcohol problems among women in European countries Dr. K. BLOOMFIELDInstitute for Medical Statistics and Informatics, Free University of Berlin, University Hospital Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, GermanyThe productivity of space and physical assets in health services across the European Union with particular emphasis on scanning services Prof. C. DAVIESUniversity of Wales, Cardiff, Bute Building, King Edward VII Avenue, Cardiff CF1 3AP, UKDeveloping a method of “willingness to pay” for assessment of community preferences for health care priorities Dr. C. DONALDSONHealth Economics Research Unit, University Medical Buildings, Foresterhill, Aberdeen AB9 2ZD, UKStudy on prevention of allergy in children in Europe Prof. J. FORSTERUniversity Children's Hospital, Mathildenstrasse 1, D-79106 Freiburg, GermanyUser specification for data exchange between institutions with responsibility for the surveillance of communicable disease within the European Union Dr. O.N. GILLCommunicable Disease Surveillance Centre, Public Health Laboratory Service, 61 Colindale Avenue, London NW9 5EQ, UKDevelopment and validation of a European standardized outcome instrument for patient evaluation of the quality of care in general practice Prof. R. GROLCentre for Quality of Care Research, Faculty of Medical Sciences, University of Nijmegen, P.O. Box 9101, NL-HB Nijmegen, The NetherlandsPublic health models: application for planning and cost-effectiveness studies Prof. L.J. GUNNING-SCHEPERSInstitute of Social Medicine (AMC), Mei
Referência(s)